On 2026-05-07, Generate Biomedicines, Inc. (GENB) announced earnings per share of -1.07 for the fiscal quarter ending 2026-03-31, missing the average analyst estimate of -0.48.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-05-07 | 2026-03-31 | -0.48 | -1.07 |